Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
7 May 24
8-K
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
7 May 24
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
8-K
Other Events
15 Apr 24
S-8
Registration of securities for employees
7 Mar 24
10-K
2023 FY
Annual report
7 Mar 24
8-K
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023
7 Mar 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Other Events
28 Nov 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
8-K
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
1 Nov 23
S-8
Registration of securities for employees
19 Sep 23
8-K
Amendments to Articles of Incorporation or Bylaws
19 Sep 23
424B4
Prospectus supplement with pricing info
18 Sep 23
EFFECT
Notice of effectiveness
18 Sep 23
CERT
Certification of approval for exchange listing
14 Sep 23
SEC STAFF LETTER
SEC staff letter
14 Sep 23
8-A12B
Registration of securities on exchange
13 Sep 23
CORRESP
Correspondence with SEC
12 Sep 23
CORRESP
Correspondence with SEC
12 Sep 23
S-1/A
IPO registration (amended)
11 Sep 23
S-1
IPO registration
25 Aug 23
CORRESP
Correspondence with SEC
25 Aug 23
UPLOAD
Letter from SEC
17 Aug 23
DRS/A
Draft registration statement (amended)
9 Aug 23
DRSLTR
Correspondence regarding draft registration statement
8 Aug 23
UPLOAD
Letter from SEC
12 Jul 23
DRS/A
Draft registration statement (amended)
30 Jun 23
DRSLTR
Correspondence regarding draft registration statement
30 Jun 23
SEC STAFF LETTER
SEC staff letter
24 May 23
UPLOAD
Letter from SEC
24 May 23
DRS/A
Draft registration statement (amended)
2 May 23
D
$474.36 mm in equity / securities to be acquired, sold $474.36 mm, 124 investors
3 Jan 23
DRS/A
Draft registration statement (amended)
2 Sep 22
DRSLTR
Correspondence regarding draft registration statement
2 Sep 22
UPLOAD
Letter from SEC
17 Jun 22
DRS/A
Draft registration statement (amended)
10 Jun 22
DRSLTR
Correspondence regarding draft registration statement
10 Jun 22
UPLOAD
Letter from SEC
16 May 22
Latest ownership filings
4
Daljit Singh Aurora
24 Apr 24
4
Joshua Pinto
16 Feb 24
4
Daljit Singh Aurora
16 Feb 24
4
Carol Y. Suh
16 Feb 24
4
PAUL L BERNS
16 Feb 24
4
Henry O Gosebruch
16 Feb 24
4
Michael Lee Milligan
16 Feb 24
4
Robert A. Lenz
16 Feb 24
SC 13G
BERNS PAUL L
14 Feb 24
SC 13G
SOFTBANK GROUP CORP.
13 Feb 24
SC 13D/A
ARCH Venture Fund XII, L.P.
15 Dec 23
4
KEITH CRANDELL
12 Dec 23
4
Change in insider ownership
12 Dec 23
4
Kristina Burow
12 Dec 23
4
Jason Duncan
12 Dec 23
3
Jason Duncan
12 Dec 23
4
Kristina Burow
15 Nov 23
4
KEITH CRANDELL
15 Nov 23
4
Kristina Burow
13 Nov 23
4
KEITH CRANDELL
13 Nov 23
4
Kristina Burow
7 Nov 23
4
KEITH CRANDELL
7 Nov 23
SC 13D
ARCH Venture Fund XII, L.P.
29 Sep 23
4
Kristina Burow
29 Sep 23
4
KEITH CRANDELL
29 Sep 23
4
Kristina Burow
27 Sep 23
4
KEITH CRANDELL
27 Sep 23
SC 13D
AMGEN INC
27 Sep 23
4
KEITH CRANDELL
25 Sep 23
4
Kristina Burow
25 Sep 23
4
Change in insider ownership
21 Sep 23
4
Kristina Burow
20 Sep 23
4
KEITH CRANDELL
20 Sep 23
4
Change in insider ownership
20 Sep 23
4
Henry O Gosebruch
19 Sep 23
4
Change in insider ownership
19 Sep 23
4
Robert A. Lenz
18 Sep 23
4
David Piacquad
18 Sep 23
4
Kristina Burow
18 Sep 23
4
Alaa Halawa
18 Sep 23